Replies to post #452793 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

AU has a trial reimbursement program FOR ALL DRUG trials held in AU. Anavex was not special.

AU is a much smaller market than the EU or the US. The extension data can be included in any application in any jurisdiction.

The large trial did have a lot of sites in AU and lots of sites in the UK, Canada, and Germany.

Maybe the TGA would look on the number of AU sites favorably. Do you think that would override the overall trial results?